Ocugen (OCGN) Reports In-Line Q4 EPS

Ocugen (NASDAQ: OCGN) reported Q4 EPS of ($0.06), in-line with the analyst estimate of ($0.06).

For earnings history and earnings-related data on Ocugen (OCGN) click here.

You May Also Be Interested In

• Ocugen, Inc. (OCGN) PT Raised to $10 at H.C. Wainwright
• Boston Scientific wins $135.7M military cardiovascular supply contract
• EigenQ and Silicon Valley Acquisition file S-4 for merger